The clinical guideline on Suspected cancer: recognition and referral (NG12) has been checked by NICE for the need for update.
This exceptional review considers the impact of faecal immunochemical tests research on NICE guidance (NICE guideline NG12 and NICE diagnostics guidance DG30 Quantitative faecal Immunochemical Tests to guide Referral for Colorectal Cancer in Primary Care.)
Registered stakeholders for the guideline are invited to comment on the provisional decision via this website.
If you’re commenting for an organisation, your organisation needs to be registered as a stakeholder.
Not eligible? Contact the registered stakeholder organisation that most closely represents your interests and pass your comments to them.
We can accept comments from individuals. These will be considered, but you won’t get a formal response and they won’t be posted on the NICE website. Wherever possible we encourage you to submit your comments through a registered stakeholder organisation.
Note that the provisional review decision presented here does not constitute NICE's formal decision on this guideline. The decision is provisional and may change after consultation.
- Surveillance review proposal (online version)
- Surveillance review proposal (PDF version)
- Supporting evidence
How to submit your response:
This consultation is using our new online commenting software. This means that we are not accepting responses on a Word form sent by email.
To leave a response you must sign into your NICE account. If you don’t already have a NICE account, you can create one.
Once you’ve signed in, you can see the questions we want you to answer by clicking on the ‘Open questions’ tab. You can then leave your responses by typing into the comment boxes. You must save each response by clicking the ‘Save answer’ button under the comment box. If you want to edit your answer, you can just type straight into the box.
Once you’ve saved all your answers, you should review them before submitting your response. There is a link to the review page at the top of the questions panel. When you’re happy with your answers, answer the questions at the bottom of the review page and click the ‘Submit my response’ button.
If you have any questions, please contact us.
All responses must be submitted by 5pm on Tuesday 24th May 2022
NICE is unable to accept:
- Comments from non-registered organisations – if you wish your comments to be considered please register via the NICE website
- Comments received after the consultation deadline (5pm)
- More than one response per stakeholder organisation
- Confidential information or other material that you would not wish to be made public
- Personal medical information about yourself or another person from which your or the person’s identity could be ascertained.
What will happen to your comments?
- Comments will be sent to the review team at the end of the consultation for their consideration
- No action will be taken upon receipt of comments from non-registered organisations and late comments.
Anticipated review decision publication date: July 2022
Further information:
-
-
-
-
-
-
-
-
-
Recommendations equalities impact assessment form (PDF 97 KB)
-
-
-
-
-
-
-
-
-
-
-
-
Referral for suspected cancer: sixteenth GDG minutes - 1 and 2 September 2014 (PDF 90 KB)
-
Referral for suspected cancer: fifteenth GDG minutes - 16 and 17 July 2014 (PDF 91 KB)
-
Referral for suspected cancer: fourteenth GDG minutes - 3 and 4 June 2014 (PDF 178 KB)
-
Referral for suspected cancer: thirteenth GDG minutes - 22 and 23 April 2014 (PDF 18 KB)
-
Referral for suspected cancer: twelfth GDG minutes - 23 and 24 March 2014 (PDF 31 KB)
-
Referral for suspected cancer: eleventh GDG minutes - 27 and 28 January 2014 (PDF 95 KB)
-
Referral for suspected cancer: tenth GDG minutes - 25 and 26 November 2013 (PDF 97 KB)
-
Referral for suspected cancer: ninth GDG minutes - 3 and 4 October 2013 (PDF 94 KB)
-
Referral for suspected cancer: eighth GDG minutes - 4 September 2013 (PDF 96 KB)
-
Referral for suspected cancer: sixth GDG minutes - 23-24 July 2013 (PDF 77 KB)
-
Referral for suspected cancer: fifth GDG minutes - 5-6 March 2013 (PDF 95 KB)
-
Referral for suspected cancer: fourth GDG minutes - 12 Dec 2012 (PDF 94 KB)
-
Referral for suspected cancer: third GDG minutes - 17 Sept 2012 (PDF 91 KB)
-
Referral for suspected cancer: second GDG minutes - 24 July 2012 (PDF 94 KB)
-
Referral for suspected cancer: first GDG minutes - 19 and 20 June 2012 (PDF 109 KB)
-
Suspected cancer: scoping equalities impact assessment form (PDF 30 KB)
-
Suspected cancer: scope consultation table with responses (PDF 620 KB)
-
-
-
This page was last updated: